Background There are only few data relating the metabolic consequences of feeding diets
very low in n-3 fatty acids. This experiment carried out in mice aims at studying the impact of …

Patients with non-alcoholic fatty liver disease are characterised by a decreased n-3/n-6
polyunsaturated fatty acid (PUFA) ratio in hepatic phospholipids. The metabolic …

Background Omega (n)-3 polyunsaturated fatty acids (PUFA) are converted to bioactive lipid
components that are important mediators in metabolic and physiological pathways; …

Long chain n-3 PUFA have been shown to have chemopreventive properties against breast
cancer through various mechanisms. One pathway, studied in human breast cancer cell …

Background Low hepatic content of n-3 PUFA has been associated with NAFLD in humans.
Whether this is associated with reduced dietary intake or increased turnover of these FA is …

Differential effects of n-3 and n-6 polyunsaturated fatty acids (PUFAs) have been
demonstrated on adipose tissue physiology. Facing to the widely recognized beneficial …

Background Dietary intake of n-3 polyunsaturated fatty acids (PUFA) is primarily recognized
to protect against cardiovascular diseases, cognitive dysfunctions and the onset of obesity …

For many years, clinical and animal studies on polyunsaturated n-3 fatty acids (PUFAs),
especially those from marine oil, eicosapentaenoic acid (20: 5, n-3) and docosahexaenoic …

Obesity is a recognized epidemic worldwide, and the accumulation of excess free saturated
fatty acids (SFAs) in cells induces cellular lipotoxic damage and increases the risk of a wide …

Increasing evidence suggests that diets high in polyunsaturated fatty acids (PUFA) confer
health benefits by improving insulin sensitivity and lipid metabolism in liver, muscle and …